Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

The latest trading day saw CVS Health (CVS) settling at $58.40, representing a -0.03% change from its previous close.

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $58.42 which represents a slight increase of $0.59 or 1.02% from the prior close of $57.83. The stock opened at $57.88 and touched a ...

While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that AI stocks hold great ...

Technical analysis for Cvs Health Corporation CVS including support levels resistance levels and stop losses for CVS ...

Financial writer's analysis of CVS Health stock. Despite solid dividends and value P/E ratio, industry pressures and risks ...

CVS Health announces that nearly 400 CVS Pharmacy locations in Massachusetts have started offering hormonal contraceptive ...

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.